Incidence of preexisting organ damage in myelodysplastic syndromes (MDS) patients without a history of chronic red blood cell (RBC) transfusion

被引：0
|
作者：
Wong, L.
Go, L.
Koss, W.
Song, J.
Wajima, T.
机构：
[1] Texas A&M Univ, Hlth Sci Ctr, Temple, TX USA
[2] Scott White Clin & Hosp, Temple, TX USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70149-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [31] UPDATE ON SAFETY AND LONG-TERM OUTCOMES IN LENALIDOMIDE (LEN)-TREATED PATIENTS WITH RED BLOOD CELL (RBC) TRANSFUSION-DEPENDENT LOW-/INT-1-RISK MYELODYSPLASTIC SYNDROMES (MDS) AND DEL(5Q)
    Hellstrom-Lindberg, E.
    Giagounidis, A.
    Selleslag, D.
    Mittelman, M.
    Muus, P.
    Benettaib, B.
    Fu, T.
    Fenaux, P.
    HAEMATOLOGICA, 2012, 97 : 358 - 359
  • [32] Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs
    Ryden, Jenny
    Clements, Mark
    Wikman, Agneta
    Hellstrom-Lindberg, Eva
    Edgren, Gustaf
    Hoglund, Petter
    TRANSFUSION, 2023, 63 (11) : 2040 - 2051
  • [33] The impact of transfusion-dependency on the outcome of patients with myelodysplastic syndromes (MDS) receiving allogeneic peripheral blood stem cell transplantation after myeloablative conditioning
    Platzbecker, Uwe
    Germing, Ulrich
    Stumpf, Julian
    Kroeger, Nikolaus
    Boehm, Anne
    Valent, Peter
    Schwerdtfeger, Rainer
    Krieger, Otto
    Kobbe, Guido
    Ehninger, Gerhard
    Bornhaeuser, Martin
    BLOOD, 2007, 110 (11) : 439A - 439A
  • [34] Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System
    Arnan, Montserrat
    Pomares, Helena
    Sanchez-Ortega, Isabel
    Alonso, Ester
    Condom, Maria
    Encuentra, Maite
    Grau, Javier
    Sureda, Anna
    BLOOD, 2016, 128 (22)
  • [35] Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes
    de Swart, Louise
    Crouch, Simon
    Hoeks, Marlijn
    Smith, Alex
    Langemeijer, Saskia
    Fenaux, Pierre
    Symeonidis, Argiris
    Cermak, Jaroslav
    Hellstrom-Lindberg, Eva
    Stauder, Reinhard
    Sanz, Guillermo
    Mittelman, Moshe
    Holm, Mette Skov
    Malcovati, Luca
    Madry, Krzysztof
    Germing, Ulrich
    Tatic, Aurelia
    Savic, Aleksandar
    Almeida, Antonio Medina
    Gredelj-Simec, Njetocka
    Guerci-Bresler, Agnes
    Beyne-Rauzy, Odile
    Culligan, Dominic
    Kotsianidis, Ioannis
    Itzykson, Raphael
    van Marrewijk, Corine
    Blijlevens, Nicole
    Bowen, David
    de Witte, Theo
    HAEMATOLOGICA, 2020, 105 (03) : 632 - 639
  • [36] Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta-analysis
    Braga Lemos, Mayra
    Rodrigues, Sarah Ramalho
    Schroeder, Thomas
    Kulasekararaj, Austin G.
    E. Matos, Joana
    Tang, Derek
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 3 - 23
  • [37] 31P MRS IN VITRO ASSAY OF PHOSPHOLIPID CHANGES IN RED BLOOD CELLS (RED) FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Kuliszkiewicz-Janus, M.
    Tuz, M.
    Kielbinski, M.
    Jazwiec, B.
    Niedoba, J.
    Baczynski, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 405 - 405
  • [38] DIRECT COST OF MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q CYTOCENETIC ABNORMALITY (DEL5Q MDS) IN PATIENTS WHO ARE RED BLOOD CELL TRANSFUSION DEPENDENT IN MEXICO
    Reyes Lopez, A.
    Lemus Villafuerte, F.
    Hernandez Rivera, C.
    Pacheco Alvarez, I
    Lemus-Carmona, E. A.
    VALUE IN HEALTH, 2015, 18 (07) : A665 - A665
  • [39] Red blood cell transfusion use in patients with chronic kidney disease
    Gill, Karminder S.
    Muntner, Paul
    Lafayette, Richard A.
    Petersen, Jeffrey
    Fink, Jeffrey C.
    Gilbertson, David T.
    Bradbury, Brian D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) : 1504 - 1515
  • [40] Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study
    Mittelman, Moshe
    Henry, David H.
    Glaspy, John
    Tombak, Anil
    Harrup, Rosemary Anne
    Madry, Krzysztof
    Grabowska, Barbara
    Platzbecker, Uwe
    Lee, Tyson
    Modelska, Katharina
    BLOOD, 2023, 142
12345